Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions
Tuberk Toraks · 23.03.2025 · 73 (1) · 80-84
DOI: 10.5578/tt.2025011040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberk Toraks, online erschienen am 24.03.2025. Verfasst von Enes Erul. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine, Ankara University Faculty of Medicine, Ankara, Türkiye.
Zitieren
APA
Erul, E. (2025). Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions. Tuberk Toraks, 73(1), 80-84. https://doi.org/10.5578/tt.2025011040
Vancouver
Erul E. Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions. Tuberk Toraks. 2025;73(1):80-84. doi:10.5578/tt.2025011040
BibTeX
@article{Erul2025,
author = {Erul, Enes},
title = {Re-evaluating perioperative and neoadjuvant immunotherapy in early-stage lung cancer: Current evidence and discussions},
journal = {Tuberk Toraks},
year = {2025},
volume = {73},
number = {1},
pages = {80--84},
doi = {10.5578/tt.2025011040}
}
EUVIMED